Amygdala
Pharmaceutical

We develop and provide a comprehensive portfolio of prescription pharmaceuticals and evidence-based nutraceuticals focused on neurosciences, psychiatry, paediatrics, orthopaedics, general medicine, and pain management, addressing diverse therapeutic needs to enhance patient care globally.

About Amygdala

“At Amygdala Pharmaceutical, we advance global health through innovative, accessible medicines. Our advanced formulations address complex needs across digestive care, neuropathic pain, brain health, nutrition, and bone support. Every product is research-driven and designed for real-world effectiveness, empowering healthcare professionals and improving patient outcomes worldwide.”

Company Overview

Corporate Identity: Amygdala Pharmaceutical Private Limited (CIN: U46497WB2024PTC271614) is an active, privately held company incorporated on June 25, 2024, and registered under the Registrar of Companies, Kolkata.
Operations: The company operates in the wholesale of pharmaceutical and medical goods, focusing on the development, marketing, and distribution of its branded product portfolio.
Core Business Segments:

Prescription Pharmaceuticals: A robust range of medications for conditions including epilepsy (BEVRIXA, VALPROXA ER), neuropathic pain (GABRIONIX ER, NORPEGA-NT), GERD/acidity (PRAZODOC-DSR), and more.

Nutraceuticals & Supplements: Scientifically formulated products for joint health (Cartuff-II, Myrafast Forte), cognitive function (CERECURA-P, MAXIMEG-3), pediatric development (Carnodale Plus), and general wellness (Q-Zac, Kalmona D3).
Key Differentiators:

Innovative Formulations: Emphasis on advanced drug delivery systems (e.g., gastro-retentive, prolonged-release) and synergistic combinations.

Science-Backed Approach: Products feature clinically studied ingredients and transparent mechanisms of action.

Broad Therapeutic Coverage: Addresses a spectrum from acute clinical conditions to chronic disease management and preventive health.
Amygdala Pharmaceuticals

Amygdala Pharmaceutical

18+ years of CNS research expertise

14+
Marketed Products
50+
Clinical Trials
1+
Countries
100+
Employees

Company Highlights

Employees

A passionate workforce committed to quality, compliance, and exceptional service in the pharmaceutical sector.

Global Reach

Strategically scaling operations with an aim to reach national and international markets in the coming years.

Financial Performance

Built on a strong operational foundation, the company continues to move forward with consistent and responsible financial progress.

Our Mission & Values

Guiding principles that define who we are and how we operate

Patient-Centricity

At Amygdala Pharmaceutical Pvt. Ltd., patient well-being is at the core of every decision we make. We are committed to delivering safe, effective, and reliable pharmaceutical solutions that improve health outcomes and enhance quality of life. Our approach focuses on understanding patient needs, ensuring product accessibility, and maintaining the highest standards of care throughout our operations.

Scientific Excellence

Scientific excellence is a driving force behind every product and process at Amygdala Pharmaceutical Pvt. Ltd. We are committed to applying evidence-based practices, advanced research insights, and rigorous scientific methods to ensure the highest quality in our formulations. Our focus on continuous improvement, accuracy, and technological advancement enables us to meet evolving healthcare needs with precision and reliability.

Integrity & Ethics

Integrity and ethics form the foundation of Amygdala Pharmaceutical Pvt. Ltd. We are committed to conducting all our operations with transparency, honesty, and accountability. Our decisions and actions are guided by strict ethical standards, regulatory compliance, and a deep sense of responsibility toward patients, partners, and the healthcare ecosystem. By upholding these principles, we build trust and long-term credibility in everything we do.

Leadership Team

Our experienced leadership team brings together decades of pharmaceutical expertise, scientific innovation, and strategic vision to advance our mission of improving lives through neuroscience.

Shibani Bose

Director – Biotechnology

Shibani Bose

Director – Biotechnology

Master’s graduate in Biotechnology from GITAM University with a strong academic foundation in biological sciences and applied biotechnology. Experienced in research methodologies, laboratory practices, and scientific analysis, with a focus on translating biotech knowledge into practical and organizational impact.

SOHAG BOSE

SOHAG BOSE

Director

35 years

SOHAG BOSE

Director

Director at Amygdala Pharmaceutical Private Limited, contributing to corporate governance and strategic oversight for the pharmaceutical company registered in West Bengal, India. Responsible for high-level leadership and regulatory compliance.

MONALISA BOSE

MONALISA BOSE

Director

20 years

MONALISA BOSE

Director

Director of Amygdala Pharmaceutical Private Limited, involved in corporate governance and strategic oversight for the company registered in West Bengal, India. Responsible for high-level decision-making and compliance with company law.

SANTISWARUP CHAKRABORTY

SANTISWARUP CHAKRABORTY

Business Advisor

30 years

SANTISWARUP CHAKRABORTY

Business Advisor

Business Advisor with 30 years of experience working with Indian conglomerates across finance, taxation, supply chain, and foreign trade. Holds a Master of Business Administration in Finance. Known for providing strategic guidance and helping organizations navigate complex business and regulatory challenges with clarity and confidence.

CA  ANKIT KUMAR SHARMA

CA ANKIT KUMAR SHARMA

Chartered Accountant

CA ANKIT KUMAR SHARMA

Chartered Accountant

Young and dynamic, Ankit Kumar Sharma is a graduate in commerce and a Fellow Member of the Institute of Chartered Accountants of India since 2012. He is successfully running his proprietorship firm, Sharma A & Associates. Since qualifying as a Chartered Accountant, he has been actively involved in professional practice, offering expert services in secretarial services, ROC filing, audit, management consultancy, and accounting services. He also holds an Information Technology Course certification from ICAI.

VIEW FULL LEADERSHIP TEAM

Comprehensive Product Portfolio

Our diverse portfolio includes pharmaceutical products addressing critical therapeutic areas across CNS disorders, cardiovascular health, oncology, and metabolic diseases.

PRAZODOC-DSR Capsule';">
Cognitive Development

PRAZODOC-DSR Capsule
Amygdala Pharmaceutical

Prazodoc-DSR Capsules are a dual-action pharmaceutical formulation designed for effective control of gastric acidity and enhanced digestive comfort. T...

Composition: Pantoprazole – 40 mg Domperidone – 30 mg
Indications: Gastroesophageal reflux disease (GERD) Acid reflux and heartburn Hyperacidity and dyspepsia Bloating and indigestion Nausea and vomiting associated with delayed gastric emptying Adjunct therapy in peptic ulcer disease
Dosage: As directed by the physician
Formulation: Capsules (DSR – Dual/Delayed Release)
Pack Size: Strip / Bottle (e.g., 10 capsules × 10 strips)
NORPEGA-NT Tablets';">
Neuro and Cognitive Support

NORPEGA-NT Tablets
Amygdala Pharmaceutical

Norpega-NT Tablets are a pharmaceutical multimodal formulation designed for effective management of peripheral neuropathic pain. The dual-action combi...

Composition: Pregabalin – 50 mg Nortriptyline – 10 mg
Indications: Peripheral neuropathic pain Diabetic neuropathy Post-herpetic neuralgia (PHN) Chronic low back pain (CLBP) Radiculopathy and nerve root pain Neuropathic pain associated with sleep disturbances
Dosage: As directed by the physician
Formulation: Tablets
Pack Size: Strip / Bottle (e.g., 10 tablets × 10 strips)
GABRIONIX ER 300 Tablets';">
Neuro and Cognitive Support

GABRIONIX ER 300 Tablets
Amygdala Pharmaceutical

Gabrionix ER-300 Tablets are a pharmaceutical formulation featuring a revolutionary gastro-retentive extended-release system that provides up to 24-ho...

Composition: Gabapentin (Extended Release) – 300 mg
Indications: Partial seizures (adjunct therapy) Neuropathic pain (diabetic neuropathy, postherpetic neuralgia) Fibromyalgia Restless leg syndrome and sleep disturbances Anxiety disorders (off-label use) Migraine prophylaxis Hot flashes and menopausal symptoms Support in alcohol and opioid withdrawal
Dosage: Dosage should be taken as prescribed by the physician.
Formulation: Extended-Release Tablets
Pack Size: Strip / Bottle (e.g., 10 tablets × 10 strips)
BEVRIXA-50 Tablets';">
Neuro and Cognitive Support

BEVRIXA-50 Tablets
Amygdala Pharmaceutical

Bevrixa-50 Tablets are a pharmaceutical antiepileptic formulation designed for advanced control of partial-onset seizures. Containing brivaracetam, th...

Composition: Brivaracetam – 50 mg
Indications: Partial-onset seizures Partial-onset seizures with or without secondary generalization Epilepsy requiring adjunctive or alternative antiepileptic therapy Patients intolerant or allergic to other antiepileptic drugs
Dosage: As directed by the physician
Formulation: Tablets
Pack Size: Strip / Bottle (e.g., 10 tablets × 10 strips)
VALPROXA ER 500 Tablets';">
Neuro and Cognitive Support

VALPROXA ER 500 Tablets
Amygdala Pharmaceutical

Valproxa ER-500 Tablets are an extended-release pharmaceutical formulation of divalproex sodium, designed for effective seizure control and mood stabi...

Composition: Divalproex Sodium (Extended Release) – 500 mg
Indications: Epilepsy and seizure disorders Bipolar disorder (manic episodes) Migraine prophylaxis Mood stabilization
Dosage: Dosage should be taken as prescribed by the physician.
Formulation: Extended-Release Tablets
Pack Size: Strip / Bottle (e.g., 10 tablets × 10 strips)
CERECURA-P Tablets';">
Neuro and Cognitive Support

CERECURA-P Tablets
Amygdala Pharmaceutical

Cerecura-P Tablets are a pharmaceutical cognitive support formulation designed to enhance memory, learning, and overall brain performance. The combina...

Composition: Piracetam – 800 mg Citicoline – 500 mg
Indications: Memory impairment and learning difficulties Reduced attention span and mental fatigue Cognitive decline and poor concentration Support for overall cognitive performance
Dosage: As directed by the physician
Formulation: Tablets
Pack Size: Strip / Bottle (e.g., 10 tablets × 10 strips)
Cartuff-II Tablets';">
Osteoarthritis and Arthritis Care

Cartuff-II Tablets
Amygdala Pharmaceutical

Cartuff-II Tablets are a pharmaceutical formulation indicated for the management of osteoarthritis and various forms of arthritis. The formulation tar...

Composition: Commiphora myrrha extract (MyrLiq®) Choline (Ch-OSA®) Curcuma longa extract (CurQlife®) Boswellia serrata extract (60%) Native Collagen Type II (Collavant® n2) Sodium Hyaluronate
Indications: Osteoarthritis (knee, hip, spine, and other joints) Rheumatoid arthritis and inflammatory arthritis Joint pain, stiffness, and reduced mobility Cartilage degeneration and joint-space narrowing Inflammation and swelling associated with arthritis
Dosage: As directed by the physician
Formulation: Tablets
Pack Size: Strip / Bottle (e.g., 10 tablets × 10 strips)
Myrafast Forte Tablets';">
Pain Relief and Joint Care

Myrafast Forte Tablets
Amygdala Pharmaceutical

Myrafast Forte Tablets are a pharmaceutical formulation designed for multimodal pain relief, because every move matters. The formulation combines adva...

Composition: MSM (Methylsulfonylmethane) – 500 mg Aflapin® (Boswellia serrata extract) – 50 mg Commiphora myrrha (MyrLiq®) – 100 mg Curcuma longa extract (CurQlife®) – 100 mg Beta Caryophyllene – 100 mg Boron – 3 mg
Indications: Acute and chronic musculoskeletal pain Osteoarthritis and inflammatory arthritis Joint pain, stiffness, and reduced mobility Inflammatory conditions associated with elevated pain markers
Dosage: As directed by the physician
Formulation: Tablets Nutraceutical for Adults
Pack Size: Net Quantity: 10 Tablets
Kalmona-D3 Tablets';">
Bone Health and Calcium Care

Kalmona-D3 Tablets
Amygdala Pharmaceutical

Kalmona-D3 Tablets are a pharmaceutical bone-health formulation designed to promote strong bones and a steady, active life. The formulation combines C...

Composition: Calcium Citrate Vitamin D3 (Cholecalciferol) Ostium® CPP
Indications: Calcium and vitamin D deficiency Osteopenia and osteoporosis Bone weakness and reduced bone mineral density Support during aging, post-menopause, and fracture recovery
Dosage: As directed by the physician
Formulation: Tablets
Pack Size: Strip / Bottle (e.g., 10 tablets × 10 strips)
Maximeg-3 Syrup';">
Brain, Memory and Healthy Aging

Maximeg-3 Syrup
Amygdala Pharmaceutical

Maximeg-3 Syrup is a pharmaceutical formulation designed to support strength, mental clarity, and healthy aging. It combines Omega-3 fatty acids (EPA ...

Composition: EPA (Eicosapentaenoic Acid) DHA (Docosahexaenoic Acid) Ginkgo Biloba Extract Vitamin D3
Indications: Cognitive decline and reduced mental alertness Memory and concentration difficulties Poor cerebral circulation Age-related weakness and reduced mobility Support for healthy aging and vitality
Dosage: Dosage should be taken as directed by the physician.
Formulation: Syrup
Pack Size: Bottle (e.g., 200 ml)
Carnodale Syrup';">
Cognitive Development

Carnodale Syrup
Amygdala Pharmaceutical

Carnodale Syrup is a pharmaceutical neuroprotective formulation designed to support critical brain development pathways, particularly the amygdala. It...

Composition: L-Carnosine
Indications: Autism Spectrum Disorder Attention Deficit Hyperactivity Disorder Specific Learning Disorder Epilepsy
Dosage: 5-10 ml BID
Formulation: Syrup
Pack Size: 200 ml
Carnodale Plus Syrup';">
Cognitive Development

Carnodale Plus Syrup
Amygdala Pharmaceutical

Carnodale Plus Syrup is a pharmaceutical neurodevelopment support formulation specially designed for children aged 2 to 14 years. It combines L-Carnos...

Composition: L-Carnosine, Docosahexaenoic Acid
Indications: Attention deficit and poor attention span Behavioral concerns and social interaction difficulties Cognitive delay and learning difficulties Delayed speech and language development
Dosage: as directed by a healthcare professional
Formulation: Syrup
Pack Size: 200 ml
Q-Zac Soft Gel Capsules';">
Neuro and Cognitive Support

Q-Zac Soft Gel Capsules
Amygdala Pharmaceutical

Q-ZAC Soft Gel Capsules are a pharmaceutical formulation designed to nourish the brain and support neurodevelopmental functions, with a focus on the a...

Composition: Omega-3 Fatty Acids Vitamin E Coenzyme Q10
Indications: Cognitive development support Learning and memory enhancement Attention and concentration difficulties Motor coordination and neuromuscular support Sensory processing challenges Social behavior and emotional regulation support
Dosage: As directed by the physician
Formulation: Soft Gel Capsules
Pack Size: Strip / Bottle

Product Portfolio Overview

Our diverse portfolio of pharmaceutical products spans multiple therapeutic categories, addressing critical healthcare needs worldwide. Each product undergoes rigorous quality control and meets global regulatory standards.

Therapeutic Categories:

  • CNS & Neurology
  • Cardiovascular
  • Oncology
  • Metabolic Disorders
  • Anti-Infective

Quality Assurance:

  • FDA/EMA Approved
  • cGMP Facilities
  • Stability Testing
  • Pharmacovigilance
  • Medical Support

Product Portfolio

13 Active Products

50+
Clinical Trials
1
Countries Served
100%
Quality Compliance
2M +
Parients Treated
Download Amygdala_Products_portfolio (PDF) Request Product Information

Research & Development

Research & Development (R&D) involves systematic work to expand knowledge and create new technologies, products, or processes. It drives innovation, competitiveness, and long-term economic growth, with data based on verified sources like OECD and UNESCO.

What Is Research & Development?

Research & Development encompasses systematic and creative efforts designed to increase the stock of human knowledge and use that knowledge to devise new applications. According to recognised international methodology, an activity qualifies as R&D only if it is novel, creative, uncertain in outcome, systematic, and potentially reproducible.

R&D typically includes:

  • Basic research: Exploration of fundamental principles without immediate commercial application.

  • Applied research: Targeted investigation geared toward specific objectives.

  • Experimental development: Using existing knowledge to create or improve products and processes

.

Manufacturing & Quality Standards

Amygdala Pharmaceutical Pvt. Ltd. is committed to delivering products that meet the highest levels of safety, purity, and effectiveness. Our manufacturing processes follow strict regulatory guidelines to ensure every formulation reflects our promise of quality and reliability.

Trusted and Certified Manufacturing Network

Amygdala Pharmaceutical Pvt. Ltd. collaborates with a network of certified manufacturing units equipped with advanced production technology and robust quality systems. These facilities follow national and international standards, enabling us to deliver dependable pharmaceutical products across diverse therapeutic categories.

Our manufacturing network is selected through strict assessment of compliance, technical capability, and quality output. By partnering with GMP-approved units, we guarantee timely production, reliable supply, and consistent adherence to regulatory requirements throughout every stage of the manufacturing cycle.

Key Manufacturing Facilities:

  • Akums Drugs & Pharmaceuticals Limited Headquarters and primary R&D manufacturing (100,000 sq ft, ISO 9001 certified)
Quality Certificates Manufacturing

Committed to Exceptional Quality

From development to delivery, we ensure every product meets uncompromised safety and performance standards.

8
Manufacturing Facilities
100%
Regulatory Compliance
ISO
Certified Facilities
24/7
Quality Monitoring

Global Presence

We serve patients in 1+ countries worldwide through our global commercial operations, with regional headquarters managing key markets.

Worldwide Operations

Amygdala Pharmaceuticals operates through 4 regional hubs that manage commercial activities across their respective territories. Our global footprint allows us to serve diverse patient populations while maintaining local expertise.

We have established commercial operations in North America, Europe, Asia-Pacific, and key emerging markets. Our products are available in 1+ countries, with ongoing expansion into additional territories.

1+
Countries
4
Regional Hubs
100+
Global Employees
5+
Local Offices

Global Reach

1+ countries served

India

Countries We Serve

India

Resources

News & Media

CERECURA-P Tablets for Cognitive Support & Brain Performance
January 24, 2026

CERECURA-P Tablets for Cognitive Support & Brain Performance

CERECURA-P Tablets combine Citicoline and Piracetam to support memory, focus, attention, and overall...

Read More
BEVRIXA-50 Tablets for Advanced Control of Partial-Onset Seizures
January 24, 2026

BEVRIXA-50 Tablets for Advanced Control of Partial-Onset Seizures

BEVRIXA-50 (Brivaracetam 50 mg) offers rapid and effective control of partial-onset seizures with im...

Read More
VALPROXA ER-500 Tablets for Seizure Control & Mood Stabilization
January 24, 2026

VALPROXA ER-500 Tablets for Seizure Control & Mood Stabilization

VALPROXA ER-500 (Divalproex Sodium ER) provides long-acting control of seizures with added mood-stab...

Read More
View All News

Careers at Amygdala

Join our team of dedicated professionals working to advance neuroscience and improve patient lives worldwide.

Why Work at Amygdala?

At Amygdala Pharmaceuticals, we offer a dynamic and collaborative work environment where innovation thrives. Our employees are at the heart of everything we do.

We provide competitive compensation, comprehensive benefits, professional development opportunities, and a culture that values diversity, inclusion, and work-life balance.

Current Opportunities

Sales

Medical Representative

📍 Location:
Asansol

📋 Type:
Full time

💰 Salary:
20,000/- to 30,000/-

⏰ Deadline:
Feb 28, 2026

We are seeking a Clinical Research Associate to join our team... ...

View All Careers

Contact Us

We welcome inquiries from healthcare professionals, patients, investors, media, and other stakeholders.

Contact Information

Headquarter

Brij Residency, G T Road, Ground Floor, Shop No. A/3, Barabani, Bardhaman, West Bengal, 713304, India.

General Inquiries

+91 9732155540
Monday - Friday, 8:00 AM - 6:00 PM IST

Email

General: care@amygdalapharmaceutical.com

Medical: care@amygdalapharmaceutical.com

Investors: care@amygdalapharmaceutical.com

Medical Information

Healthcare professionals: +91 9732155540

Patients: +91 9732155540

Pharmacovigilance: care@amygdalapharmaceutical.com

Follow Us

Send Us a Message